Health & Research Goals
GLOW Blend
Mezcla GLOW
Synergistic Blend
Select a vial or the total
Primary Description
General research of a combined systemic protocol where each peptide exponentially amplifies the catalytic or hormonal pathway of the other, producing the most forceful response of the investigated vector.
Demonstrated Effects
- Combined synergistic effect
- Maximized research outputs
- Pre-verified protocol
Proposed Mechanisms of Action
Combined Mechanism
BPC-157 activates VEGF and EGF receptor pathways to promote angiogenesis, wound healing, and tissue remodeling in the dermis. TB-500 mobilizes thymosin β-4, which binds G-actin to drive cell migration, extracellular matrix remodeling, and neo-vasculogenesis in aging skin. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) upregulates over 4,000 genes including COL1A1 (collagen I), COL3A1 (collagen III), metalloproteinase inhibitors (TIMP-1/2), and antioxidant enzymes (SOD, catalase) — effectively resetting the gene expression profile of aged skin toward a younger state.
Stack Compounds
Research Evidence & Clinical Data
Research Profile
The signature skin regeneration and anti-aging triple blend. BPC-157 and TB-500 provide deep tissue healing, angiogenesis, and connective tissue remodeling; GHK-Cu — the most extensively researched copper tripeptide — drives collagen synthesis, skin tightening, and antioxidant gene expression. Together they address all three layers of skin aging: vascular, structural, and genetic.
Scientific References
- 1.
- 2.
Safety Profile
Common Side Effects
- Monitor injection sites for redness or swelling
- Use sterile reconstitution technique — peptide blends require bacteriostatic water
- Discard if solution is cloudy, discolored, or contains particulates after reconstitution
- Copper peptides may interact with topical retinoids — stagger applications
- Store reconstituted solution at 2-8°C and use within 28 days
Contraindications
- Wilson's disease or copper metabolism disorder
- Known hypersensitivity to any component
- Active skin infection at injection site
- Pregnancy
Analytical Quality Assurance
Research Protocols
Dosing Protocols
Maintenance Protocol (General Anti-Aging)
Subcutaneous (abdomen, thigh, or upper arm)Intensive Protocol (Active Healing/Rejuvenation)
SubcutaneousAdministration
Add 2–3 mL bacteriostatic water to vial. Gently swirl (do not shake).
Refrigerate reconstituted solution (2–8°C). Use within 30 days.
Can be administered any time of day. Some prefer evening for overnight repair processes.
Rotate sites to prevent tissue irritation. Common sites include abdomen, thighs, upper arms.
Expectations Timeline
Day 1–7: Initial Effects
- Improved skin hydration and glow
- Reduced inflammation if present
- Enhanced sense of well-being
Week 2–4: Early Changes
- Noticeable improvement in skin texture and tone
- Reduction in fine lines
- Accelerated healing of minor wounds or blemishes
- Improved hair quality and growth
Week 4–8: Significant Effects
- Visible reduction in wrinkle depth
- Improved skin firmness and elasticity
- Enhanced collagen density (measurable)
- Reduction in scars and hyperpigmentation
Week 8–12: Peak Effects
- Maximum collagen remodeling and skin improvement
- Sustained anti-aging benefits
- Optimal tissue repair and regeneration
- Transition to maintenance dosing for sustained results
Monitoring & Risk Management
Compound Stack Monitoring
For stacks and blends, refer to the individual compound monographs for each included ingredient for specific monitoring guidelines.